Mankind Pharma Limited and Innovent Biologics have announced partnership to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenge...
India’s medical devices exports rose at a CAGR of 14% from FY20 to reach reach $3.8 billion in FY24. However, the country continues to remain a net importer of medical devices, bringing in 80-85% of its domestic requirements from abroad...
The 2nd edition of Pack.Nxt 2024 concluded successfully at The Lalit, Mumbai, bringing together industry pioneers, policymakers, and sustainability advocates to explore the theme "Smart | Circular | Sustainable."
Manmohan Singh, frequently referred to as a "reluctant king" in his initial term as prime minister, died on Thursday, December 26, at the age of 92. A gentle-spoken leader, Singh was India's prime minister from 2004 to 2014, positioning him among...
The market for pharmaceutical water is propelled by the increasing need for premium-quality pharmaceutical water in various uses, including parenteral solutions, intravenous fluids, and active pharmaceutical ingredients (APIs). Tight regulations...
The pharmaceutical sector, projected to nearly double to about USD 130 billion by 2030, aims to leverage favorable policies, demographics, and digital expertise to position India as a key player in enhancing global health for everyone...
In the pharmaceutical industry, a revenue growth of 9-11 percent is expected for FY25 and FY26, supported by digital transformation, increased internet availability, and broader expansion in Tier-I and Tier-II cities. The top local brokerage has...
The Precision Medicine Software market is fueled by the rising occurrence of chronic illnesses, progress in genomics, and heightened consumer interest in tailored healthcare solutions. The increasing prevalence of cancer, heart diseases, and...
The expansion of the global pharmaceutical eCommerce market is fueled by the swift embrace of digital platforms within the healthcare sector, with projections indicating a compound annual growth rate (CAGR) of 14.4% from 2024 to 2034. The market...
Verismo Therapeutics and HLB Innovation will expedite the clinical advancement of SynKIR-110 and SynKIR-310 for patients with solid tumors and blood cancers, respectively, reinforcing the shared goal of Verismo and HLB Group to promote their...
, CDSCO.jpg)
